share_log

FOXO Technologies | 424B3: Prospectus

SEC announcement ·  Jan 23 00:00
Summary by Moomoo AI
FOXO Technologies Inc. has filed a prospectus supplement to update and supplement information contained in its previous prospectus dated July 6, 2023. This filing is related to the potential offer and resale of up to 19,312,823 shares of Class A common stock by selling stockholders. The shares include those issued to stockholders who tendered warrants during an exchange offer, approved amendments to senior promissory notes, and those issued in exchange for a general release related to convertible debentures issued by Legacy FOXO. The company will not receive any proceeds from the sale of shares by the selling stockholders. FOXO Technologies Inc. is listed on the NYSE American LLC under the symbol 'FOXO' and had a closing price of $0.2950 per share on January 22, 2024. Additionally...Show More
FOXO Technologies Inc. has filed a prospectus supplement to update and supplement information contained in its previous prospectus dated July 6, 2023. This filing is related to the potential offer and resale of up to 19,312,823 shares of Class A common stock by selling stockholders. The shares include those issued to stockholders who tendered warrants during an exchange offer, approved amendments to senior promissory notes, and those issued in exchange for a general release related to convertible debentures issued by Legacy FOXO. The company will not receive any proceeds from the sale of shares by the selling stockholders. FOXO Technologies Inc. is listed on the NYSE American LLC under the symbol 'FOXO' and had a closing price of $0.2950 per share on January 22, 2024. Additionally, the company's public warrants are quoted on the OTC Pink Marketplace under the symbol 'FOXOW' with a closing price of $0.0025 on the same date. The company is considered an 'emerging growth company' and has elected to comply with reduced public company reporting requirements. On January 12, 2024, FOXO Technologies entered into a material definitive agreement with KR8 AI Inc., granting a perpetual license to use Licensor Products for developing an AI machine learning epigenetic app. The agreement includes an initial license and development fee, a monthly maintenance fee, and an ongoing royalty based on subscriber revenues. The company issued 1,300,000 shares of common stock to KR8 AI Inc. as part of the agreement. The prospectus supplement is dated January 23, 2024.

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more